Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs: 1 blog
twitter: 24 X users

wikipedia: 5 Wikipedia pages
guideline: 4 clinical guideline sources

Readers on

mendeley: 278 Mendeley

So far, Altmetric has seen 6 Guidelines that reference this research output.

2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease.

Clinical guideline published by U.S. Department of Veterans Affairs on 30 Dec 2025

The United States Department of Veterans Affairs is a Cabinet-level executive branch department of the federal government charged with integrating life-long healthcare services to eligible military veterans at the 1700 VA medical centers and outpatient clinics located throughout the country.

Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology

Clinical guideline published by Polish Society of Nephrology (PTN) on 02 Dec 2024

The Polish Society of Nephrology (PTN) is dedicated to advancing nephrology in Poland through education, research, and clinical guidelines. It offers resources for nephrologists, including publications, events, and a platform for collaboration among professionals in the field.

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Clinical guideline published by Kidney Disease: Improving Global Outcomes (KDIGO) on 01 Apr 2024

Kidney Disease: Improving Global Outcomes (KDIGO) is a global nonprofit organization dedicated to enhancing kidney disease care through evidence-based clinical practice guidelines. Their mission focuses on translating scientific evidence into practical recommendations for clinicians and patients worldwide.

Clinical practice guideline for the diagnosis and treatment of cardiorenal syndrome (2023 Edition)

Clinical guideline published by Chinese Medical Association (CMA) on 12 Dec 2023

The Chinese Medical Association (CMA) is a prominent non-profit organization established in 1915, uniting around 700,000 medical professionals across 89 specialty societies. It fosters medical science development, facilitates academic exchanges, and publishes numerous medical journals and educational resources.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 2 additional posts.